265 related articles for article (PubMed ID: 16584384)
21. A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b.
Aoki N; Matsuda T
J Biol Chem; 2000 Dec; 275(50):39718-26. PubMed ID: 10993888
[TBL] [Abstract][Full Text] [Related]
22. Inadequacy of the Janus kinase 2/signal transducer and activator of transcription signal transduction pathway to mediate episodic growth hormone-dependent regulation of hepatic CYP2C11.
Verma AS; Dhir RN; Shapiro BH
Mol Pharmacol; 2005 Mar; 67(3):891-901. PubMed ID: 15591245
[TBL] [Abstract][Full Text] [Related]
23. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
[TBL] [Abstract][Full Text] [Related]
24. Codependence of growth hormone-responsive, sexually dimorphic hepatic gene expression on signal transducer and activator of transcription 5b and hepatic nuclear factor 4alpha.
Holloway MG; Laz EV; Waxman DJ
Mol Endocrinol; 2006 Mar; 20(3):647-60. PubMed ID: 16239260
[TBL] [Abstract][Full Text] [Related]
25. Molecular interactions of EphA4, growth hormone receptor, Janus kinase 2, and signal transducer and activator of transcription 5B.
Sawada T; Arai D; Jing X; Miyajima M; Frank SJ; Sakaguchi K
PLoS One; 2017; 12(7):e0180785. PubMed ID: 28686668
[TBL] [Abstract][Full Text] [Related]
26. Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone.
Ram PA; Waxman DJ
J Biol Chem; 2000 Dec; 275(50):39487-96. PubMed ID: 10991939
[TBL] [Abstract][Full Text] [Related]
27. Characterization of three growth hormone-responsive transcription factors preferentially expressed in adult female liver.
Laz EV; Holloway MG; Chen CS; Waxman DJ
Endocrinology; 2007 Jul; 148(7):3327-37. PubMed ID: 17412818
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A.
Kazansky AV; Kabotyanski EB; Wyszomierski SL; Mancini MA; Rosen JM
J Biol Chem; 1999 Aug; 274(32):22484-92. PubMed ID: 10428824
[TBL] [Abstract][Full Text] [Related]
29. Insulin inhibits growth hormone signaling via the growth hormone receptor/JAK2/STAT5B pathway.
Ji S; Guan R; Frank SJ; Messina JL
J Biol Chem; 1999 May; 274(19):13434-42. PubMed ID: 10224108
[TBL] [Abstract][Full Text] [Related]
30. Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor.
Le MN; Kohanski RA; Wang LH; Sadowski HB
Mol Endocrinol; 2002 Dec; 16(12):2764-79. PubMed ID: 12456798
[TBL] [Abstract][Full Text] [Related]
31. The role of signal transducer and activator of transcription 5 in the inhibitory effects of GH on adipocyte differentiation.
Richter HE; Albrektsen T; Billestrup N
J Mol Endocrinol; 2003 Apr; 30(2):139-50. PubMed ID: 12683938
[TBL] [Abstract][Full Text] [Related]
32. Novel signal transduction pathway for luteinizing hormone and its interaction with insulin: activation of Janus kinase/signal transducer and activator of transcription and phosphoinositol 3-kinase/Akt pathways.
Carvalho CR; Carvalheira JB; Lima MH; Zimmerman SF; Caperuto LC; Amanso A; Gasparetti AL; Meneghetti V; Zimmerman LF; Velloso LA; Saad MJ
Endocrinology; 2003 Feb; 144(2):638-47. PubMed ID: 12538627
[TBL] [Abstract][Full Text] [Related]
33. Regulation of JAK2 protein expression by chronic, pulsatile GH administration in vivo: a possible mechanism for ligand enhancement of signal transduction.
Zhou Y; Wang X; Hadley J; Corey SJ; Vasilatos-Younken R
Gen Comp Endocrinol; 2005 Nov; 144(2):128-39. PubMed ID: 15993410
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia activates the cyclin D1 promoter via the Jak2/STAT5b pathway in breast cancer cells.
Joung YH; Lim EJ; Lee MY; Park JH; Ye SK; Park EU; Kim SY; Zhang Z; Lee KJ; Park DK; Park T; Moon WK; Yang YM
Exp Mol Med; 2005 Aug; 37(4):353-64. PubMed ID: 16155412
[TBL] [Abstract][Full Text] [Related]
35. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms.
Ram PA; Waxman DJ
J Biol Chem; 1999 Dec; 274(50):35553-61. PubMed ID: 10585430
[TBL] [Abstract][Full Text] [Related]
36. Identification of SH2-bbeta as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2.
Rui L; Carter-Su C
Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7172-7. PubMed ID: 10377387
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional inhibition by Stat5. Differential activities at growth-related versus differentiation-specific promoters.
Luo G; Yu-Lee L
J Biol Chem; 1997 Oct; 272(43):26841-9. PubMed ID: 9341115
[TBL] [Abstract][Full Text] [Related]
38. An immunohistochemical approach to monitor the prolactin-induced activation of the JAK2/STAT5 pathway in pancreatic islets of Langerhans.
Brelje TC; Svensson AM; Stout LE; Bhagroo NV; Sorenson RL
J Histochem Cytochem; 2002 Mar; 50(3):365-83. PubMed ID: 11850439
[TBL] [Abstract][Full Text] [Related]
39. Elevated basal expression of liver peroxisomal beta-oxidation enzymes and CYP4A microsomal fatty acid omega-hydroxylase in STAT5b(-/-) mice: cross-talk in vivo between peroxisome proliferator-activated receptor and signal transducer and activator of transcription signaling pathways.
Zhou YC; Davey HW; McLachlan MJ; Xie T; Waxman DJ
Toxicol Appl Pharmacol; 2002 Jul; 182(1):1-10. PubMed ID: 12127257
[TBL] [Abstract][Full Text] [Related]
40. Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2.
VanderKuur J; Allevato G; Billestrup N; Norstedt G; Carter-Su C
J Biol Chem; 1995 Mar; 270(13):7587-93. PubMed ID: 7535773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
